Tissue microarray-chip featuring computerized immunophenotypical characterization more accurately subtypes ampullary...

Area of Science:

• Gastroenterology and Oncology
• Tumor Subtyping
• Immunohistochemistry

Background:

• Ampullary adenocarcinomas (AACs) are heterogeneous, with Intestinal (INT), Pancreato-Biliary (PB), and Mixed-Type (MT) subtypes.
• Current classification by histology alone is challenging.
• Subtypes exhibit differential responses to chemotherapy and prognoses.

Purpose of the Study:

• To develop an immunohistochemical (IHC) scoring system to classify AACs into two main subtypes.
• To differentiate between Intestinal (INT) and Pancreato-Biliary (PB) phenotypes.

Main Methods:

• Utilized HE histology and IHC for CDX2, CK7, and CK20 on 21 AAC tissue samples.
• Developed a global score (GS) based on IHC expression and intensity.
• Classified MT tumors into INT or PB groups based on predominant IHC markers.

Main Results:

• The IHC scoring system successfully classified AACs into two distinct histo-molecular phenotypes.
• INT subtype characterized by high CDX2/CK20 expression; PB subtype by high CK7/low CK20 expression.
• INT subtype demonstrated significantly better overall survival (85.7 months) compared to the PB subtype (20.3 months).

Conclusions:

• Histopathological and molecular criteria combined classify AACs into two clinically relevant phenotypes.
• These phenotypes represent distinct disorders with implications for therapeutic strategies.
• The IHC scoring system offers a more precise method for AAC subtyping.